Retatrutide and Fertility

The relationship between obesity and infertility is well-established and bidirectional. Excess body weight disrupts reproductive hormones, impairs gamete quality, reduces conception rates, and increases pregnancy complications. For couples struggling with infertility, weight loss is often one of the most effective and underutilized interventions. GLP-1 medications like retatrutide offer a path to the significant weight loss needed to restore fertility -- but they come with important timing and safety considerations that every patient must understand.

Weight Loss and Female Fertility

Obesity impairs female fertility through multiple mechanisms. Excess adipose tissue disrupts the hypothalamic-pituitary-ovarian axis, leading to irregular or absent ovulation. Elevated insulin and androgens (particularly in PCOS) create an inhospitable hormonal environment for conception. Obesity reduces egg quality and endometrial receptivity. And even with conception, obese women face higher rates of miscarriage, gestational diabetes, preeclampsia, and birth complications.

Weight loss of 5-10% can restore ovulatory cycles in many women, reduce miscarriage risk, and improve IVF success rates. The 24% weight loss with retatrutide would be expected to provide dramatic fertility improvement, potentially resolving obesity-related infertility entirely in many cases.

Weight Loss and Male Fertility

Male obesity impairs fertility through reduced testosterone (via aromatization of testosterone to estrogen in fat tissue), impaired sperm quality (reduced count, motility, and morphology), erectile dysfunction and reduced sexual frequency, and increased scrotal temperature from excess fat. Weight loss reverses most of these effects, with testosterone recovery being particularly important. Men do not need to discontinue GLP-1 medications for conception, as these drugs have not shown direct effects on sperm or male reproductive organs.

Treatment Timing and Planning

• Start treatment early: If planning pregnancy in 6-12 months, start weight loss medication now to achieve significant weight loss before discontinuation.
• Discontinue 2+ months before conception: This allows medication clearance and metabolic stabilization.
• Use reliable contraception during treatment: Weight loss can restore fertility unexpectedly -- do not rely on previous anovulation as contraception.
• Consider non-oral contraception: GLP-1 medications may affect oral contraceptive absorption.
• Maintain healthy habits: The lifestyle habits established during treatment (nutrition, exercise) help maintain weight and fertility after medication stops.

Plan Your Path to Parenthood

Compounded semaglutide ($99/mo) and compounded tirzepatide ($125/mo) can help you achieve a healthier weight before conception. Our providers understand reproductive planning considerations and can help time treatment appropriately.